Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

VOLUNTARY ANNOUNCEMENT - UPDATES ON CLINICAL DATA FROM PHASE II CLINICAL STUDY OF KN046 COMBINED WITH CHEMOTHERAPY IN THE FIRST-LINE TREATMENT OF PDAC FOR PRESENTATION AT 2021 CSCO ANNUAL MEETING 2021-09-17
VOLUNTARY ANNOUNCEMENT - RESEARCH RESULTS ON KN046 AND KN026 FOR PRESENTATION AT ESMO CONGRESS 2021 2021-09-13
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021 2021-09-06
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2021 2021-08-27
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION 2021-08-27
CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR 2021-08-27
VOLUNTARY ANNOUNCEMENT - EXCLUSIVE COLLABORATION WITH CSPC IN RELATION TO THE DEVELOPMENT AND COMMERCIALIZATION OF KN026 IN MAINLAND CHINA 2021-08-23
DATE OF BOARD MEETING 2021-08-16
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021 2021-08-05
VOLUNTARY ANNOUNCEMENT - ABSTRACTS AND E-POSTERS OF RESEARCH UPDATES ON KN046 AND KN026 FOR PRESENTATION AT ESMO CONGRESS 2021 2021-07-26

15 16 17 18 19 20 21